Suchergebnisse
Idaho Strategic Resources, Inc. (IDR) Q2 Earnings and Revenues Lag Estimates
Idaho Strategic Resources, Inc. (IDR) came out with quarterly earnings of $0.23 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.2 per share a year
Yeti (YETI) Surpasses Q2 Earnings and Revenue Estimates
Yeti (YETI) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.66 per share a year ago. These figures are
A.P. Moller-Maersk (AMKBY) Beats Q2 Earnings and Revenue Estimates
A.P. Moller-Maersk (AMKBY) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.2 per share a year ago. These
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago. These figures
Birkenstock (BIRK) Q3 Earnings Lag Estimates
Birkenstock (BIRK) came out with quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.7 per share a year ago. These figures
Wacker Neuson Q2 Earnings Call Highlights
Key Points
- Interested in Wacker Neuson SE? Here are five stocks we like better.
- Strong first-half performance: Revenue rose 17% to €1.26 billion, while EBIT nearly doubled to about €105
3 Great Mutual Fund Picks for Your Retirement
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The best way to shortlist great
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
The easiest way to judge a
Nomad Foods (NOMD) Tops Q2 Earnings and Revenue Estimates
Nomad Foods (NOMD) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.45 per share a year ago. These
Tapestry (TPR) Tops Q4 Earnings Estimates
Tapestry (TPR) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.04 per share a year ago. These figures
Bullish (BLSH) Q2 Earnings and Revenues Top Estimates
Bullish (BLSH) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.05 per share a year ago. These figures are
Kolibri Global Energy Inc. (KGEI) Q2 Earnings and Revenues Beat Estimates
Kolibri Global Energy Inc. (KGEI) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.08 per share a year
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins
Omnicell, Inc. OMCL raised its 2026 earnings outlook after a better-than-expected second quarter, but part of the profit improvement came from a one-time tariff refund.
The next test is whether
Is the Options Market Predicting a Spike in Brookfield Business Partners Stock?
Investors in Brookfield Business Corporation BBUC need to pay close attention to the stock based on moves in the options market lately. That is because the October 16, 2026 $20.00 Call had some of
Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation
Edwards Lifesciences Corporation EW shares have gained 14% in the past three months as growth across its structural-heart franchises has strengthened the operating case. Second-quarter results
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.5 per share a year ago. These
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Beats Revenue Estimates
Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $1.53. This compares to a loss of $4.32 per share a year ago. These
GDS Holdings (GDS) Misses Q2 Earnings and Revenue Estimates
GDS Holdings (GDS) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $1.35 per share. This compares to a loss of $0.06 per share a year ago. These figures
Can GE Vernova's Strong Q2 Results Fuel Further Earnings Growth?
GE Vernova Inc.’s GEV second-quarter 2026 results suggest that the company is entering a stronger earnings growth phase. The company delivered significant growth in orders and revenues, expanded
Are Options Traders Betting on a Big Move in Beacon Financial Stock?
Investors in Beacon Financial Corporation BBT need to pay close attention to the stock based on moves in the options market lately. That is because the September 18, 2026 $25.00 Call had some of the


